Neogen Corp (NEOG.O)
21.29USD
9 Feb 2010
$0.25 (+1.19%)
$21.29
--
$21.31
$20.85
29,663
49,774
$24.70
$11.00
NEOG.O
About
Overall
| Beta: | 0.66 |
| Market Cap (Mil.): | $478.83 |
| Shares Outstanding (Mil.): | 22.49 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| NEOG.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 31.83 | 1.96 | 3.76 |
| EPS (TTM): | 13.06 | -- | -- |
| ROI: | 11.25 | 0.92 | 2.30 |
| ROE: | 11.62 | 1.27 | 2.82 |
US-RESEARCH/ (NON-S&P500)
Mead Johnson Citigroup Starts with buy; price target of $32 Nutrition
US RESEARCH SUMMARY-Non-S&P 500 March 23 2210 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 March 23 1701 GMT
Following is a summary of research actions on non-S&P 500 companies reported
UPDATE 1-Neogen posts Q3 profit below Street; shares fall
March 19 (Reuters) - Neogen Corp , which makes diagnostic devices for research and food safety, posted quarterly results below market estimates, hurt by the weak global economy, sending its shares down to their lowest in more than a year.
BRIEF-Neogen Corp Q2 results
Jan 3 (Reuters) - NEOGEN CORP : * Reports 34 percent increase in net income, 23 percent increase in revenues * Second quarter adjusted earnings per share $0.22 * Reuters Estimates second quarter earnings per share view $0.21 * Second quarter revenue rose 23 percent to $27.21 million * Reuters Estimates second quarter revenue view $25.81 million * Says outlook for rest of the fiscal year is encouraging
TABLE-Neogen Q1 earnings rise
NEOGEN CORP (In $) Latest Yr ago qtr EPS (diluted) 0.21 0.17 Net (million) 3.0 2.4 Total Revenue (million) 22.9 20.2 Reuters Estimates: EPS $0.19 (two analysts), revenue $23.1 million (two analysts)
TABLE-Neogen Q1 earnings rise
NEOGEN CORP (In $) Latest Yr ago qtr EPS (diluted) 0.21 0.17 Net (million) 3.0 2.4 Total Revenue (million) 22.9 20.2 Reuters Estimates: EPS $0.19 (two analysts), revenue $23.1 million (two analysts)
Neogen announces three-for-two stock split
NEW YORK, July 26 (Reuters) - Neogen Corp. said on Thursday its board approved a three-for-two stock split.
TABLE-Neogen Q4 profit rises
NEOGEN CORP. (In $) Latest Yr ago qtr EPS (diluted) 0.24 0.20 Net (million) 2.3 1.7 Total revenue (million) 22.7 19.8 Reuters Estimates: EPS $0.24, revenue $22.2 million. --The maker of food and animal safety products said results for the year-ago quarter were restated to include stock-based compensation expense, which reduced the net income for the period by $
Competitors
| Price | Change | |
|---|---|---|
| Applied Biosystems Inc. (ABI.N) | -- | -- |
| IDEXX Laboratories, Inc. (IDXX.OQ) | $50.56 | +0.57 |
| Meridian Bioscience, Inc. (VIVO.OQ) | $20.45 | +0.48 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
